The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
Antibody studies analyze immune responses to SARS-CoV-2 vaccination and infection,
which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted …
which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted …
Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection
JJ Cabrera-Alvargonzalez, C Davina-Nunez… - Infectious …, 2024 - Taylor & Francis
Background To infer a reliable SARS-CoV-2 antibody protection level from a serological test,
an appropriate quantitative threshold and solid equivalence across serological tests are …
an appropriate quantitative threshold and solid equivalence across serological tests are …
Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
S Holdenrieder, CE dos Santos Ferreira… - Frontiers in Public …, 2023 - frontiersin.org
Much of the global population now has some level of adaptive immunity to SARS-CoV-2
induced by exposure to the virus (natural infection), vaccination, or a combination of both …
induced by exposure to the virus (natural infection), vaccination, or a combination of both …
[HTML][HTML] Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich …
C Janke, R Rubio-Acero, M Weigert, C Reinkemeyer… - …, 2024 - pmc.ncbi.nlm.nih.gov
This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including
asymptomatic cases, focusing on infection risks during the Omicron wave, particularly …
asymptomatic cases, focusing on infection risks during the Omicron wave, particularly …
Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2
S Ouoba, A Sugiyama, K Ko, UK Mirzaev… - Journal of Medical …, 2024 - Wiley Online Library
Commercially available assays for measuring severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) anti‐spike (S) or anti‐nucleocapsid (N) antibodies differ in …
coronavirus 2 (SARS‐CoV‐2) anti‐spike (S) or anti‐nucleocapsid (N) antibodies differ in …
[PDF][PDF] The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare …
C Reinkemeyer, Y Khazaei, M Weigert, M Hannes… - 2023 - pdfs.semanticscholar.org
Antibody studies analyze immune responses to SARS-CoV-2 vaccination and infection,
which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted …
which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted …